1. Home
  2. NMI vs VANI Comparison

NMI vs VANI Comparison

Compare NMI & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Municipal Income Fund Inc.

NMI

Nuveen Municipal Income Fund Inc.

HOLD

Current Price

$10.76

Market Cap

119.5M

Sector

Finance

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.18

Market Cap

100.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMI
VANI
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.5M
100.0M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
NMI
VANI
Price
$10.76
$1.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
19.3K
188.4K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.62
$0.92
52 Week High
$11.18
$1.92

Technical Indicators

Market Signals
Indicator
NMI
VANI
Relative Strength Index (RSI) 52.10 42.71
Support Level $9.88 $1.13
Resistance Level $10.88 $1.55
Average True Range (ATR) 0.23 0.06
MACD -0.00 0.00
Stochastic Oscillator 57.25 20.00

Price Performance

Historical Comparison
NMI
VANI

About NMI Nuveen Municipal Income Fund Inc.

Nuveen Municipal Income Fund Inc is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income exempt from federal income tax, which it seeks to achieve by investing mainly in a diversified portfolio of tax-exempt municipal obligations.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

Share on Social Networks: